Cardiac Tamponade Market Size Information: By Diagnosis
(X-Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Coronary
Angiography, Electrocardiogram (EKG), others) By Treatment (Surgery
(Pericardiocentesis, Thoracotomy, others), Drugs (Antibiotics, Blood Volume
Expanders, others)) By End Users - Global Forecast till 2023
Market
Highlights:
Cardiac Tamponade Market Size, is the build-up of fluid in the sac around
the heart (pericardium) resulting in pressure and difficulty in compression of
the heart. Difficulty in compression of the heart results in reduced blood
volume to be pumped by the heart. The symptoms of cardiac tamponade include
shortness of breath, weakness, light-headedness, cough, fatigue, swelling of
the abdomen, veins in the arms or legs, or other areas, pale skin, or skin that
is blue- or gray-tinted, rapid heartbeat, anxiety or restlessness, fainting
etc. The causes of cardiac tamponade are cancer, kidney failure, chest trauma,
and pericarditis, connective tissue diseases, hypothyroidism, aortic rupture,
following cardiac surgery, tuberculosis etc. Cardiac tamponade can be
life-threatening if not treated. Risk factors which increases the chances of
cardiac tamponade include heart surgery, heart attack, injury to the heart,
end-stage lung cancer, radiation therapy to the chest, hypothyroidism, systemic
lupus erythematosus etc.
The diagnosis
segment of cardiac tamponade especially the non-invasive Magnetic Resonance
Imaging (MRI) is growing fast. Magnetic Resonance Imaging (MRI) is the diagnostic
test of choice. The surgery segment is led by pericardiocentesis which involves
drainage of the fluid by use of a needle. Cardiac tamponade has a frequency of
approximately 2 per 10,000 per year in the US.
The market drivers
for Cardiac Tamponade Market Size are increasing cardiac cases such as heart
attack, other factors includes cancer, kidney failure, end-stage lung cancer,
hypothyroidism, rising screening and penetration of healthcare, growing
awareness about cardiac diseases and growing income and healthcare expenditure
etc. The market restraints are cost of cardiac tamponade surgery, complications
and risk of the surgery, invasive nature of treatment etc.
Global Cardiac
Tamponade Market Size Players
Key players profiled
in the report are Boston Scientific Corporation, Medtronic, Inc., St. Jude
Medical Inc., Hitachi, Ltd., Koninklijke Philips N.V., Siemens Healthcare
Private Limited, and Toshiba Medical Systems Corporation, General Electric
Company, and others.
Regional Analysis
The Americas
accounts for a significant market share owing to extensive use of medications
and high expenditure on the health care. Additionally, the fastest uptake of
new drugs in the US drives the Cardiac Tamponade Market Size. Also,
concentration of major research companies in the developed countries of this
region is adding fuel to the market growth. The large US expenditure on
healthcare accounting to 16% of GDP also cruises the sale of cardiac tamponade
treatment. The large number of specialized cardiac centres in the US also
drives the market.
Europe is the second
largest market in the world due to high income and healthcare penetration.
Europe is led by nations such as Germany and France. UK is expected to be the
fastest growing market.
Asia Pacific region
is expected to grow rapidly and China and India are likely to lead this market
due to fast growing healthcare sector during the forecast period.
Gulf nations such as
Saudi Arabia and the UAE are estimated to drive the Middle East & African
market. The development of large hospitals such as the King Fahd hospital in
Riyadh is driving the market. The African region is expected to witness a
moderate growth owing to poor economic and political conditions and poor
healthcare development.
Taste the market
data and market information presented through more than 50 market data tables
and figures spread over 80 pages of the project report. Avail the in-depth
table of content (TOC) & market synopsis on “Global Cardiac Tamponade
Market Size” Research Report – Forecast till 2023.
Segmentation
The global Cardiac
Tamponade Market Size has been segmented on the basis of diagnosis, treatment,
and end user.
Based on diagnosis,
the market has been segmented as X-ray, Computed Tomography (CT), Magnetic
Resonance Imaging (MRI), coronary angiography, electrocardiogram (EKG), and
others.
Based on treatment,
the market has been segmented as surgery and drugs. The surgery segment has
been sub-segmented as pericardiocentesis, thoracotomy and others. The drugs
segment has been sub-segmented as antibiotics, blood volume expanders and
others.
Based on the end
user, the market has been segmented as hospitals & clinics, academic and
research and others.
No comments:
Post a Comment